Certified Specialist Programme in AI Trustworthiness in Drug Discovery
-- viewing nowAI Trustworthiness in Drug Discovery Ensures the reliability and efficacy of AI models in pharmaceutical research. The Certified Specialist Programme in AI Trustworthiness in Drug Discovery is designed for professionals working in the field of artificial intelligence and drug discovery.
6,936+
Students enrolled
GBP £ 149
GBP £ 215
Save 44% with our special offer
About this course
It aims to equip learners with the knowledge and skills necessary to develop and validate AI models that meet the highest standards of trustworthiness.
Through a combination of theoretical foundations and practical applications, learners will gain a deep understanding of the challenges and opportunities in AI trustworthiness.
By the end of the programme, learners will be able to design and implement AI models that are reliable, efficient, and effective in drug discovery.
Join the programme and take the first step towards ensuring the trustworthiness of AI in drug discovery.
100% online
Learn from anywhere
Shareable certificate
Add to your LinkedIn profile
2 months to complete
at 2-3 hours a week
Start anytime
No waiting period
Course details
•
Machine Learning in Drug Discovery: This unit covers the application of machine learning algorithms in drug discovery, including data preprocessing, feature selection, and model evaluation. It also discusses the use of deep learning techniques in generating new drug candidates and predicting their efficacy. •
AI for Predictive Toxicity: This unit focuses on the use of artificial intelligence and machine learning to predict the toxicity of drug candidates. It covers the development of predictive models using large datasets and the application of these models in early drug discovery. •
Data Quality and Preprocessing for AI in Drug Discovery: This unit emphasizes the importance of data quality and preprocessing in AI-driven drug discovery. It covers the techniques for handling missing data, feature scaling, and data normalization. •
Explainable AI in Drug Discovery: This unit discusses the need for explainable AI in drug discovery, where the model's decisions and predictions are transparent and interpretable. It covers techniques such as feature importance, partial dependence plots, and SHAP values. •
AI for Personalized Medicine: This unit explores the application of AI in personalized medicine, where AI-driven models are used to predict the efficacy of drugs in individual patients. It covers the use of genomics, proteomics, and other omics data in personalized medicine. •
Adversarial Attacks and Defenses in AI for Drug Discovery: This unit discusses the threat of adversarial attacks in AI-driven drug discovery, where malicious actors attempt to manipulate the model's predictions. It covers techniques for defending against adversarial attacks, such as data augmentation and regularization. •
AI for Drug Repurposing: This unit focuses on the use of AI in drug repurposing, where existing drugs are repurposed for new indications. It covers the development of predictive models using large datasets and the application of these models in identifying new drug targets. •
AI for Biomarker Discovery: This unit explores the application of AI in biomarker discovery, where AI-driven models are used to identify biomarkers for disease diagnosis and prognosis. It covers the use of machine learning algorithms and deep learning techniques in identifying biomarkers. •
AI for Clinical Trial Design: This unit discusses the use of AI in clinical trial design, where AI-driven models are used to optimize trial design and patient recruitment. It covers the development of predictive models using large datasets and the application of these models in identifying high-priority clinical trials. •
AI Trustworthiness in Drug Discovery: This unit covers the importance of AI trustworthiness in drug discovery, where the model's predictions and decisions are reliable and trustworthy. It discusses the techniques for ensuring AI trustworthiness, such as data quality control, model interpretability, and explainability.
Machine Learning in Drug Discovery: This unit covers the application of machine learning algorithms in drug discovery, including data preprocessing, feature selection, and model evaluation. It also discusses the use of deep learning techniques in generating new drug candidates and predicting their efficacy. •
AI for Predictive Toxicity: This unit focuses on the use of artificial intelligence and machine learning to predict the toxicity of drug candidates. It covers the development of predictive models using large datasets and the application of these models in early drug discovery. •
Data Quality and Preprocessing for AI in Drug Discovery: This unit emphasizes the importance of data quality and preprocessing in AI-driven drug discovery. It covers the techniques for handling missing data, feature scaling, and data normalization. •
Explainable AI in Drug Discovery: This unit discusses the need for explainable AI in drug discovery, where the model's decisions and predictions are transparent and interpretable. It covers techniques such as feature importance, partial dependence plots, and SHAP values. •
AI for Personalized Medicine: This unit explores the application of AI in personalized medicine, where AI-driven models are used to predict the efficacy of drugs in individual patients. It covers the use of genomics, proteomics, and other omics data in personalized medicine. •
Adversarial Attacks and Defenses in AI for Drug Discovery: This unit discusses the threat of adversarial attacks in AI-driven drug discovery, where malicious actors attempt to manipulate the model's predictions. It covers techniques for defending against adversarial attacks, such as data augmentation and regularization. •
AI for Drug Repurposing: This unit focuses on the use of AI in drug repurposing, where existing drugs are repurposed for new indications. It covers the development of predictive models using large datasets and the application of these models in identifying new drug targets. •
AI for Biomarker Discovery: This unit explores the application of AI in biomarker discovery, where AI-driven models are used to identify biomarkers for disease diagnosis and prognosis. It covers the use of machine learning algorithms and deep learning techniques in identifying biomarkers. •
AI for Clinical Trial Design: This unit discusses the use of AI in clinical trial design, where AI-driven models are used to optimize trial design and patient recruitment. It covers the development of predictive models using large datasets and the application of these models in identifying high-priority clinical trials. •
AI Trustworthiness in Drug Discovery: This unit covers the importance of AI trustworthiness in drug discovery, where the model's predictions and decisions are reliable and trustworthy. It discusses the techniques for ensuring AI trustworthiness, such as data quality control, model interpretability, and explainability.
Career path
**Certified Specialist Programme in AI Trustworthiness in Drug Discovery**
**Career Roles and Statistics**
| **Role** | **Description** | **Industry Relevance** |
|---|---|---|
| **AI/ML Engineer** | Design and develop artificial intelligence and machine learning models for drug discovery, ensuring trustworthiness and accuracy. | Highly relevant to the pharmaceutical industry, where AI can improve drug development and reduce costs. |
| **Data Scientist (AI)** | Analyze and interpret complex data to identify patterns and trends in drug discovery, ensuring trustworthiness and accuracy. | Essential for the pharmaceutical industry, where data-driven decision-making is crucial for drug development. |
| **AI Ethicist** | Ensure that AI systems in drug discovery are fair, transparent, and unbiased, addressing ethical concerns and trustworthiness. | Critical in the pharmaceutical industry, where AI can impact patient outcomes and public trust. |
Entry requirements
- Basic understanding of the subject matter
- Proficiency in English language
- Computer and internet access
- Basic computer skills
- Dedication to complete the course
No prior formal qualifications required. Course designed for accessibility.
Course status
This course provides practical knowledge and skills for professional development. It is:
- Not accredited by a recognized body
- Not regulated by an authorized institution
- Complementary to formal qualifications
You'll receive a certificate of completion upon successfully finishing the course.
Why people choose us for their career
Loading reviews...
Frequently Asked Questions
Debug: False
Course fee
MOST POPULAR
Fast Track
GBP £149
Complete in 1 month
Accelerated Learning Path
- 3-4 hours per week
- Early certificate delivery
- Open enrollment - start anytime
Standard Mode
GBP £99
Complete in 2 months
Flexible Learning Pace
- 2-3 hours per week
- Regular certificate delivery
- Open enrollment - start anytime
What's included in both plans:
- Full course access
- Digital certificate
- Course materials
All-Inclusive Pricing • No hidden fees or additional costs
Get course information
Earn a career certificate
CERTIFIED SPECIALIST PROGRAMME IN AI TRUSTWORTHINESS IN DRUG DISCOVERY
is awarded to
Learner Name
who has completed a programme at
London School of Planning and Management (LSPM)
Awarded on
05 May 2025
Blockchain Id: s-1-a-2-m-3-p-4-l-5-e
Add this credential to your LinkedIn profile, resume, or CV. Share it on social media and in your performance review.
